570 likes | 718 Views
Diabetes Update. Maximizing options to achieve optimal blood glucose control. Carla Cox, PhD, RD, CDE. Be able to identify 3 lifestyle recommendations that could change your patients life with diabetes
E N D
Diabetes Update Maximizing options to achieve optimal blood glucose control Carla Cox, PhD, RD, CDE
Be able to identify 3 lifestyle recommendations that could change your patients life with diabetes • Be able to list 3 classes of diabetes medications and their target tissues and when to consider using them • Understand the potential for technology to enhance your patients ability to partner in the management of their blood glucose Objectives
American diabetes Association American Academy of Clinical Endocrinologists What ARE those BG Goals?
ADA < 7% (with clinical judgment on co-morbid conditions) What ARE those BG Goals?
50% of Kaiser Permanente Northwest patients who initiated metformin-sulfonylurea combination therapy failed to maintain A1C levels below 8%....and it was 3 YEARS before insulin was added and at that time mean A1C of 9% (Nichols et al, 2007) • UK population using 2 agents had A1C of at least 8% for 6.9 YEARS before further intensification of therapy with mean A1C of 9.1% (Khuntiet al, 2013) WE NEED TO DO BETTER THAN THIS! What’s the data?
Not evil, not promoting health Quality
Think and teach balance: A fruit or vegetable with every meal – and don’t forget the whole grains!
Minimum • Aerobic Exercise 150 minutes per week (3-5 days per week) • Strength training 2-3 times per week • Stretching 5 days of the week Exercise – American College of Sports Medicine
Exercise most days of the week • Include strength and aerobic exercise when possible – think about the order Exercise – diabetes specific
Consider timing of the meal with exercise and present medication regimen • Follow minimum standards of ACSM (no evidence that stretching per se is needed) Exercise – diabetes specific
Benefits • Helps to maintain/reach a healthy weight • Treatment of osteoarthritis and rheumatoid arthritis • Greater emotional health and better sleep!
Benefits • Reduced risk of developing: • Diabetes • Heart disease • Stroke • Cancers • High blood pressure
More data: 4 cookies for afternoon snack 10/16 ; ice cream sundae 10/18 More data: Took a walk 10/17 afternoon and had 2 cookies for afternoon snack Using the data
More data: 4 cookies for afternoon snack 10/16 ; ice cream sundae 10/18 More data: Took a walk 10/17 afternoon and had 2 cookies for afternoon snack Using the data – what should we change?
Medications Remember – the goal is BG control, not necessarily how we get there!
When lifestyle doesn’t do it (or doesn’t happen) 1921 – Insulin is discovered (thank you dogs!) 1923 – Insulin is produced by Eli Lilly 1936 – first slower insulin (NPH type) • 1955 – Sulfonylureas • 1983 – 2nd generation of Sulfonylureas • 1997 - Thiazolidinediones Medications
When lifestyle doesn’t do it (or doesn’t happen) - 2014 • Biguanide • Metformin/biguanide • Secretagogues • Glucatrol/Glipizide • Amaryl/glimiprimide • Meglitinides • Prandin/repaglinide • Starlix/nateglinide • TZD • Actos/Pioglitazaone • Alpha-Glucosidase Inhibitors • Precose/acarbose • Glyset/miglitol • GLP-1 (incretins and incretinmimetics) • Byetta/exenatide (BID) • Victoza/liraglutide (1/day) • Bydureon/exenatide (weekly) • Tanzeum/albiglutide (weekly) • Trulicity/dulaglutide (weekly) (11/18) • DPP-4 • Januvia/sitagliptin • Onglyza/saxagliptin • Tradjenta/linagliptin • Nesina/alogliptin • SGLT-2 (sodium-glucose co-transporter) • Invocana/Canagliflozin • Farxiga/Dapagliflozin • Jardiance/Empagliflozin • Combination drugs (such as Janumet) • Insulin • Basal • Bolus • Premixed Medications
GLP-1 receptor agonistsA1C 1-1.5 http://www.globalrph.com/DPP-4-inhibitors.htm
Monitor with renal insufficiency (CrCl< 30 mL/min) • Patients with history or risk of pancreatitis (insufficient clinical evidence to support this) • Patients with personal or family history of thyroid c-cell tumors (not seen in humans) • Individuals with stomach or intestinal issues may not be candidates Who should NOT use this medication
DPP-4 inhibitors A1C .5-1 http://www.globalrph.com/DPP-4-inhibitors.htm
Reduce dose in renal insufficiency (with the exception of Trajenta) Who should not use this medication
Patients with hypovolemia • Caution with the elderly – especially using diuretics • Patients with GFR below 45 mL/min (Farxiga/Dapagliflozin) – below 60 mL/min) Who should not use this medication
Phillips et al, We can change the natural history of type 2 diabetes, Diabetes Care 2014;37-2668-2676
Phillips et al, We can change the natural history of type 2 diabetes, Diabetes Care 2014;37-2668-2676
CefaluW, Del Prato S, LeRoith D et al. Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management: Reflections from a Diabetes Care Editors Expert Forum. Diabetes Care 2014;37:267-2659. Medication review
Insulin delivery • Pens - .5 – 1 unit • Pumps (including V-Go) • U-500 insulin option • Blood glucose results • Meters • Sensors (additional layer) Delivering insulin anddiscovering results
There is a relationship between frequency of A1C testing and better BG management results • Those testing annually had a 1.5% increase • Those testing every 3 months had a 3.8% decrease • Those who tested more often did not improve beyond the quarterly checks Diabetes Care 2014;37:2731-2737 A1C testing
Patient is 54 year old patient with A1C of 8.5%. He has abdominal obesity and is sedentary. No significant joint problems. He works 50 hours per week, and works around the house on the week-ends. He is presently on Metformin and Glipizide. Renal and liver function tests are WNL. He denies symptoms such as frequent urination, thirst, excessive fatigue • What do you do? Case #1
Patient is 54 year old patient with A1C of 8.5%. He has abdominal obesity and is sedentary. No significant joint problems. He works 50 hours per week, and works around the house on the week-ends. He is presently on Metformin and Glipizide. Renal and liver function tests are WNL • Consider referral to diabetes education – even a 2nd time • Add a medication – which one? • Make sure he is monitoring effectively (pre and post meal) • Have him return for f/u or follow up with SOMEONE in 1-2 weeks Case #1